$ZNTL
Zentalis Pharmaceuticals, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$2.79
▲+10.58%+$0.267
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateZentalis Pharmaceuticals, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is ZNTL up today? It is at $2.79 (+10.58%), and our scanner flagged it 66 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ZNTL spikes, and full due diligence on ZNTL — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ZNTL 66 times in the last 30 days. Create a free account to track $ZNTL, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
ZNTL is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 15 unusual-volume and momentum alerts on ZNTL today, peaking at 39.4x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Bruns Ingmar Officer | Acquired (grant/award) | +10K 0.01% of company | added 29% | 43K | $21K at $2.18 | Sep 30, 26 |
Walters Group Beneficial Owner (10%) | Bought (open market) | +4.33M 6.0% of company | added 32% | 17.84M | $15.2M at $3.50 | Aug 14, 26 |
Myers Scott Dunseth Director | Acquired (grant/award) | +57K 0.08% of company | added 17% | 396K | n/a | Jun 16, 26 |
Kariuki Enoch Director | Acquired (grant/award) | +57K 0.08% of company | added 42% | 194K | n/a | Jun 16, 26 |
Walker Luke Nathaniel Director | Acquired (grant/award) | +57K 0.08% of company | added 40% | 201K | n/a | Jun 16, 26 |
Skvarka Jan Director | Acquired (grant/award) | +57K 0.08% of company | added 28% | 264K | n/a | Jun 16, 26 |
Johnson David Michael Director | Acquired (grant/award) | +57K 0.08% of company | added 23% | 308K | n/a | Jun 16, 26 |
Campbell Shannon Director | Acquired (grant/award) | +114K 0.2% of company | n/a | 114K | n/a | May 26, 26 |
Vultaggio Vincent Officer | Sold (automatic/other) | -7K | sold 4.5% | 147K | $17K at $2.42 | Feb 10, 26 |
Eastland Julia Marie Officer | Sold (automatic/other) | -889 | sold 1.1% | 79K | $2K at $2.39 | Feb 9, 26 |
Vultaggio Vincent Officer | Sold (automatic/other) | -3K | sold 2.2% | 153K | $8K at $2.39 | Feb 9, 26 |
Bruns Ingmar Officer | Sold (automatic/other) | -335 | sold 1.0% | 33K | $801 at $2.39 | Feb 9, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
ZNTL is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 15 unusual-volume and momentum alerts on ZNTL today, peaking at 39.4x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
ZNTL last traded at $2.79, up 10.58% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL) is next expected to report earnings on Monday, November 9, 2026, about 35 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ZNTL Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ZNTL 66 times in the last 30 days.
ZNTL (Zentalis Pharmaceuticals, Inc. Common Stock) trades on XNAS, with a market cap of about $181M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ZNTL for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ZNTL discussion
Sign in to ask a question or join the discussion.